128 results
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
generally requires a two-thirds majority vote by shareholders, whereas DGCL generally only requires a majority vote; and (ii) under the BCBCA, one or more … is a resolution (i) passed at a shareholders’ meeting by a simple majority, or (ii) passed, after being submitted to all of the shareholders, by being
8-K
EX-10.1
qlbtz61pvplzen
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-4.2
3xb7oai
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-4.1
7fwju5w
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
5yltv
11 Apr 24
Prospectus supplement for primary offering
9:06am
424B5
haxpk61l6covl
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
waoy01e
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-4.1
vj2e7
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
vxl1ip0oufuw cnvnsrn
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
3f4up4fhav345jb
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.1
j3yitd8
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm